NEW YORK (360Dx) – Ambry Genetics, a Konica Minolta company, said this week that it is collaborating with the National Institutes of Health-funded Undiagnosed Diseases Network to "facilitate transition" of patients with negative or uncertain test results to the UDN in hopes of providing them with answers.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.